A new partnership between the American Cancer Society and the Melanoma Research Alliance will fund research aimed at decreasing side effects associated with checkpoint inhibitors in hopes of increasing further cancer immunotherapy benefits. FDA has approved use of checkpoint drugs to combat seven cancer types including lung, head and neck, kidney cancer, bladder cancer, Merkel...
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
